NCT04413513

Brief Summary

Older adults with anxiety symptoms was found to be associated with greater risk of dementia. Interventions targeting signs as early as in the pre-symptomatic phase could be most effective in early prevention of dementia. On reviewing the identified non-pharmacological interventions, integrated attention training program (IATP) is proposed to target older adults with anxiety symptoms in Hong Kong.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 13, 2018

Completed
Same day until next milestone

Study Start

First participant enrolled

August 13, 2018

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2018

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 7, 2019

Completed
1.4 years until next milestone

First Posted

Study publicly available on registry

June 4, 2020

Completed
Last Updated

June 4, 2020

Status Verified

May 1, 2020

Enrollment Period

5 months

First QC Date

August 13, 2018

Last Update Submit

May 28, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Attention network test (ANT)

    ANT will measure the changes in attention from baseline to endpoint between the intervention and control groups. Performance was based on (i) accuracy refers to the degree of correctness and also to quality control, which means that if the participant's accuracy fell below 70%, the case would be considered unqualified. (2) reaction time refers to the processing speed. Median values of RT will be used as raw scores to avoid the influence of outliers. The indices will be served to compare the effect of IATP and health education.

    T1: baseline, T2: 4th week, T3:12th week

Secondary Outcomes (12)

  • Subjective memory complaints (SMC)

    T1: baseline, T2: 4th week, T3:12th week

  • Clinical Dementia Rating (CDR)

    T1: baseline, T2: 4th week, T3:12th week

  • Digit and visual spans

    T1: baseline, T2: 4th week, T3:12th week

  • Delayed recall

    T1: baseline, T2: 4th week, T3:12th week

  • Category verbal fluency tests

    T1: baseline, T2: 4th week, T3:12th week

  • +7 more secondary outcomes

Study Arms (2)

Integrated Attention Training Program

EXPERIMENTAL

The intervention group (I) will receive "integrated attention training program (IATP)" on a variety of structured attention tasks by an intervention instructor. It is considered to be simple and safe but effective enough for cognitive health promotion.

Other: Integrated Attention Training Program (IATP)

Health Education

PLACEBO COMPARATOR

The control group (C) will receive health educational sessions on health concerns and physical diseases commonly found in old age during the invention period.

Other: Health Education

Interventions

Integrated attention training program (IATP) is a newly developed cognitive training programs that combined relaxation technique with integrated attentional training into daily life activity.

Integrated Attention Training Program

Health educational sessions on health concerns and physical diseases commonly found in old age

Health Education

Eligibility Criteria

Age60 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Older adults aged 60 - 90 years; and
  • Presence of subjective memory complaints as measured by memory inventory for the Chinese; and
  • Anxiety symptoms as measured by Hamilton Anxiety Scale (HAM-A) with a score of 18 or above (indicated as mild anxiety symptoms).

You may not qualify if:

  • DSM-5 diagnosis of either Major Neurocognitive Disorder due to AD, or Major Vascular Neurocognitive Disorder with small vessel disease. This would include satisfying criteria for significant cognitive decline in at least one of six areas of cognition (memory, perceptual-motor, complex attention, language, executive function and social cognition), and with clinical or neuroimaging features indicative of either AD or small vessel disease; or;
  • Clinical dementia rating larger than or equal to 0.5; or
  • Clinically depressed as assessed by Hamilton Depression Rating Scale with a score of 20 or higher; or
  • Past history of major depressive episode, bipolar affective disorders or psychosis; or
  • Physical frailty that may affect attendance to training sessions; or
  • Currently on psychotropic or other medications know to affect cognition (e.g., benzodiazepines, anti-dementia medication, etc.); or
  • Participants in other cognitive training or intervention for brain health during the study period; or
  • Presence of major neurological deficit including history of stroke, transient ischemic attack or traumatic brain injury; or
  • Significant communicative impairment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Hong Kong Polytechnic University

Hong Kong, Hong Kong

Location

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Wai Tung Fung, PhD

    The Hong Kong Polytechnic University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 13, 2018

First Posted

June 4, 2020

Study Start

August 13, 2018

Primary Completion

December 31, 2018

Study Completion

January 7, 2019

Last Updated

June 4, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Locations